Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biohaven (BHVN) Shares Outstanding (Weighted Average) (2021 - 2026)

Biohaven has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $147.6 million for Q1 2026.

  • Quarterly results put Shares Outstanding (Weighted Average) at $147.6 million for Q1 2026, up 44.8% from a year ago — trailing twelve months through Mar 2026 was $147.6 million (up 44.8% YoY), and the annual figure for FY2025 was $107.6 million, up 17.97%.
  • Shares Outstanding (Weighted Average) reached $147.6 million in Q1 2026 per BHVN's latest filing, up from $107.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $147.6 million in Q1 2026 and bottomed at $39.4 million in Q1 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $81.6 million (2024), compared with a mean of $79.9 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) rose 0.02% in 2022 before it soared 73.51% in 2023.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $44.7 million in 2022, then surged by 59.14% to $71.2 million in 2023, then grew by 28.14% to $91.2 million in 2024, then increased by 17.97% to $107.6 million in 2025, then skyrocketed by 37.16% to $147.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BHVN at $147.6 million in Q1 2026, $107.6 million in Q4 2025, and $105.8 million in Q3 2025.